Please select the option that best describes you:
Topics:
Breast Cancer • Medical Oncology
How do you approach chemotherapy use in patients with locally advanced ER+/HER2 negative patients with cirrhosis and platelets < 100K?
For instance, in stage III, would you use chemotherapy in neoadjuvant or adjuvant setting? What regimen would you use?
Answer from: Medical Oncologist at Academic Institution
This is fortunately a rare situation encountered in breast cancer patients but in those situations it poses a challenging problem. In general, I look at this as two categories: In patients with compensated cirrhosis (with Child-Pugh score less than 7 and no clinically detectable ascites), the mortal...
Sign in or Register to read more